$709 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 106 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 29.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TARS | Buy | TARSUS PHARMACEUTICALS INC | $38,038,213 | +18.3% | 2,140,586 | +20.3% | 5.37% | +13.4% |
| MIRM | MIRUM PHARMACEUTICALS INC | $35,932,581 | +22.1% | 1,137,107 | 0.0% | 5.07% | +17.1% | |
| ANAB | ANAPTYSBIO INC | $35,032,938 | -11.7% | 1,950,609 | 0.0% | 4.94% | -15.4% | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $33,130,522 | +38.8% | 3,440,345 | +29.8% | 4.68% | +33.1% |
| EOLS | EVOLUS INC | $28,310,227 | +25.7% | 3,097,399 | 0.0% | 4.00% | +20.5% | |
| IMGN | Buy | IMMUNOGEN INC | $23,805,000 | -3.0% | 1,500,000 | +15.4% | 3.36% | -7.0% |
| New | EQRX INC | $22,391,164 | – | 10,086,110 | +100.0% | 3.16% | – | |
| AXSM | AXSOME THERAPEUTICS INC | $22,364,800 | -2.7% | 320,000 | 0.0% | 3.16% | -6.8% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $21,050,640 | -13.4% | 405,600 | 0.0% | 2.97% | -17.0% | |
| NYCB | NEW YORK CMNTY BANCORP INC | $18,218,844 | +0.9% | 1,606,600 | 0.0% | 2.57% | -3.3% | |
| LLY | ELI LILLY & CO | $16,113,900 | +14.5% | 30,000 | 0.0% | 2.27% | +9.8% | |
| ITCI | INTRA-CELLULAR THERAPIES INC | $15,627,000 | -17.7% | 300,000 | 0.0% | 2.20% | -21.2% | |
| PCVX | VAXCYTE INC | $15,294,000 | +2.1% | 300,000 | 0.0% | 2.16% | -2.2% | |
| BGNE | BEIGENE LTDsponsored adr | $15,288,950 | +0.9% | 85,000 | 0.0% | 2.16% | -3.3% | |
| BLUE | Sell | BLUEBIRD BIO INC | $13,019,794 | -46.4% | 4,282,827 | -42.0% | 1.84% | -48.6% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $12,744,000 | -26.1% | 1,800,000 | -26.5% | 1.80% | -29.2% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $12,572,112 | – | 397,600 | +100.0% | 1.77% | – |
| AZN | ASTRAZENECA PLCsponsored adr | $11,512,400 | -5.4% | 170,000 | 0.0% | 1.62% | -9.3% | |
| THIRD HARMONIC BIO INC | $11,502,000 | +32.8% | 1,800,000 | 0.0% | 1.62% | +27.3% | ||
| AVIR | Buy | ATEA PHARMACEUTICALS INC | $10,800,000 | -4.6% | 3,600,000 | +19.0% | 1.52% | -8.5% |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $10,422,000 | +23.4% | 600,000 | 0.0% | 1.47% | +18.2% | |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $10,300,000 | – | 1,000,000 | +100.0% | 1.45% | – |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $10,264,378 | -37.7% | 669,125 | -3.4% | 1.45% | -40.3% |
| IONS | IONIS PHARMACEUTICALS INC | $9,072,000 | +10.6% | 200,000 | 0.0% | 1.28% | +6.0% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $8,887,224 | -6.9% | 271,200 | 0.0% | 1.25% | -10.7% | |
| BIO | Buy | BIO RAD LABS INCcl a | $8,602,800 | +41.8% | 24,000 | +50.0% | 1.21% | +35.9% |
| IFRX | Sell | INFLARX NV | $8,416,572 | -34.9% | 2,824,353 | -2.6% | 1.19% | -37.6% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $8,320,500 | -26.7% | 6,450,000 | -2.3% | 1.17% | -29.7% |
| New | DIANTHUS THERAPEUTICS INC | $8,087,664 | – | 591,636 | +100.0% | 1.14% | – | |
| NVCR | Buy | NOVOCURE LTD | $7,947,415 | +91.5% | 492,100 | +392.1% | 1.12% | +83.5% |
| MRNA | MODERNA INC | $7,922,343 | -15.0% | 76,700 | 0.0% | 1.12% | -18.5% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $7,840,800 | +171.3% | 180,000 | +125.0% | 1.11% | +159.6% |
| Sell | VERASTEM INC | $7,248,009 | -14.5% | 891,514 | -21.8% | 1.02% | -18.1% | |
| ALT | ALTIMMUNE INC | $7,150,000 | -26.3% | 2,750,000 | 0.0% | 1.01% | -29.4% | |
| ZYMEWORKS INC | $6,974,000 | -26.6% | 1,100,000 | 0.0% | 0.98% | -29.7% | ||
| BCAB | Buy | BIOATLA INC | $6,423,268 | -41.7% | 3,778,393 | +2.8% | 0.91% | -44.2% |
| QURE | New | UNIQURE NV | $6,279,218 | – | 935,800 | +100.0% | 0.89% | – |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $5,827,500 | +301.3% | 750,000 | +400.0% | 0.82% | +284.1% |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $5,621,299 | +16.1% | 621,138 | +38.0% | 0.79% | +11.2% |
| EQC | Buy | EQUITY COMWLTH | $5,511,000 | +172.0% | 300,000 | +200.0% | 0.78% | +161.1% |
| AVRO | Buy | AVROBIO INC | $5,409,536 | +110.5% | 3,512,686 | +29.9% | 0.76% | +101.9% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $5,393,516 | -36.2% | 5,862,517 | -17.4% | 0.76% | -38.8% |
| GRPH | Sell | GRAPHITE BIO INC | $5,001,232 | -7.8% | 2,016,626 | -3.3% | 0.71% | -11.5% |
| ADMA | Buy | ADMA BIOLOGICS INC | $4,868,800 | +4.7% | 1,360,000 | +7.9% | 0.69% | +0.4% |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $4,431,000 | +14.3% | 300,000 | 0.0% | 0.62% | +9.5% | |
| INSM | INSMED INC | $4,196,626 | +19.7% | 166,203 | 0.0% | 0.59% | +14.7% | |
| C | CITIGROUP INC | $4,113,000 | -10.7% | 100,000 | 0.0% | 0.58% | -14.5% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,030,224 | -10.8% | 5,166,954 | +5.7% | 0.57% | -14.6% |
| CRTX | Sell | QUINCE THERAPEUTICS INC | $3,918,732 | -27.9% | 3,498,868 | -3.2% | 0.55% | -31.0% |
| VBTX | VERITEX HLDGS INC | $3,769,500 | +0.1% | 210,000 | 0.0% | 0.53% | -4.0% | |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $3,699,322 | -13.3% | 3,557,040 | +6.7% | 0.52% | -16.9% |
| BIOHAVEN LTD | $3,641,400 | +8.7% | 140,000 | 0.0% | 0.51% | +4.3% | ||
| Buy | ASLAN PHARMACEUTICALS LTDspon ads new | $3,574,918 | -13.2% | 1,901,552 | +68.6% | 0.50% | -16.8% | |
| GNFT | Sell | GENFIT S Aads | $3,402,880 | -22.1% | 1,040,636 | -15.7% | 0.48% | -25.3% |
| CVBF | CVB FINL CORP | $3,314,000 | +24.8% | 200,000 | 0.0% | 0.47% | +19.7% | |
| USB | US BANCORP DEL | $3,306,000 | +0.1% | 100,000 | 0.0% | 0.47% | -4.1% | |
| RAIN | RAIN ONCOLOGY INC | $3,223,426 | -28.2% | 3,740,341 | 0.0% | 0.46% | -31.2% | |
| DSGN | New | DESIGN THERAPEUTICS INC | $3,186,000 | – | 1,350,000 | +100.0% | 0.45% | – |
| GLPG | GALAPAGOS NVspon adr | $3,097,408 | -15.0% | 89,650 | 0.0% | 0.44% | -18.6% | |
| ENZ | Sell | ENZO BIOCHEM INC | $3,080,000 | -27.2% | 2,200,000 | -4.3% | 0.44% | -30.2% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $3,073,500 | – | 150,000 | +100.0% | 0.43% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $2,982,000 | – | 200,000 | +100.0% | 0.42% | – |
| Buy | LIANBIOsponsored ads | $2,682,000 | +22.3% | 1,800,000 | +87.1% | 0.38% | +17.0% | |
| ELEV | ELEVATION ONCOLOGY INC | $2,650,400 | -56.4% | 4,000,000 | 0.0% | 0.37% | -58.2% | |
| ALGS | ALIGOS THERAPEUTICS INC | $2,486,799 | -23.1% | 3,329,048 | 0.0% | 0.35% | -26.3% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $2,346,426 | +2822.1% | 3,939,600 | +2722.1% | 0.33% | +2658.3% |
| Sell | MEI PHARMA INC | $2,285,849 | -3.8% | 326,084 | -9.7% | 0.32% | -7.7% | |
| TANGO THERAPEUTICS INC | $2,252,000 | +239.2% | 200,000 | 0.0% | 0.32% | +224.5% | ||
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,084,000 | – | 100,000 | +100.0% | 0.29% | – |
| PDSB | Buy | PDS BIOTECHNOLOGY CORP | $2,020,000 | +301.6% | 400,000 | +300.0% | 0.28% | +285.1% |
| HRTX | HERON THERAPEUTICS INC | $1,905,500 | -11.2% | 1,850,000 | 0.0% | 0.27% | -14.9% | |
| New | BIONOMICS LIMITEDads | $1,890,000 | – | 700,000 | +100.0% | 0.27% | – | |
| EGRX | EAGLE PHARMACEUTICALS INC | $1,874,375 | -18.9% | 118,857 | 0.0% | 0.26% | -22.4% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $1,813,000 | -29.5% | 1,850,000 | 0.0% | 0.26% | -32.5% | |
| KRTX | New | KARUNA THERAPEUTICS INC | $1,690,900 | – | 10,000 | +100.0% | 0.24% | – |
| ACET | Sell | ADICET BIO INC | $1,680,102 | -72.1% | 1,226,352 | -50.5% | 0.24% | -73.3% |
| New | JOURNEY MED CORP | $1,578,514 | – | 576,100 | +100.0% | 0.22% | – | |
| ARVN | ARVINAS INC | $1,571,200 | -20.9% | 80,000 | 0.0% | 0.22% | -24.0% | |
| SFBS | SERVISFIRST BANCSHARES INC | $1,565,100 | +27.5% | 30,000 | 0.0% | 0.22% | +22.1% | |
| EDIT | EDITAS MEDICINE INC | $1,560,000 | -5.2% | 200,000 | 0.0% | 0.22% | -9.1% | |
| SBTX | ARS PHARMACEUTICALS INC | $1,547,770 | -43.6% | 409,463 | 0.0% | 0.22% | -46.0% | |
| NKTX | Sell | NKARTA INC | $1,534,057 | -49.5% | 1,103,638 | -20.4% | 0.22% | -51.7% |
| CHRS | COHERUS BIOSCIENCES INC | $1,496,000 | -12.4% | 400,000 | 0.0% | 0.21% | -15.9% | |
| BOH | BANK HAWAII CORP | $1,490,700 | +20.5% | 30,000 | 0.0% | 0.21% | +15.4% | |
| FATE | FATE THERAPEUTICS INC | $1,484,000 | -55.5% | 700,000 | 0.0% | 0.21% | -57.4% | |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $1,148,000 | – | 400,000 | +100.0% | 0.16% | – |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $936,400 | +4.9% | 10,000 | 0.0% | 0.13% | +0.8% | |
| TGTX | New | TG THERAPEUTICS INC | $836,000 | – | 100,000 | +100.0% | 0.12% | – |
| LIFE | Buy | ATYR PHARMA INC | $744,392 | +129.8% | 471,134 | +214.1% | 0.10% | +118.8% |
| ATHA | ATHIRA PHARMA INC | $712,484 | -31.5% | 352,715 | 0.0% | 0.10% | -34.0% | |
| GOSS | New | GOSSAMER BIO INC | $698,386 | – | 838,600 | +100.0% | 0.10% | – |
| MASS | 908 DEVICES INC | $666,000 | -2.9% | 100,000 | 0.0% | 0.09% | -6.9% | |
| Sell | INVIVYD INC | $623,111 | -48.5% | 366,536 | -68.2% | 0.09% | -50.6% | |
| NXTC | NEXTCURE INC | $516,000 | -28.3% | 400,000 | 0.0% | 0.07% | -31.1% | |
| Sell | INSPIRATO INCORPORATED | $516,590 | -49.1% | 875,577 | -15.4% | 0.07% | -51.0% | |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $458,171 | – | 159,087 | +100.0% | 0.06% | – |
| STELLAR BANCORP INC | $426,400 | -6.9% | 20,000 | 0.0% | 0.06% | -10.4% | ||
| SELB | SELECTA BIOSCIENCES INC | $424,000 | -5.4% | 400,000 | 0.0% | 0.06% | -9.1% | |
| MOLN | Buy | MOLECULAR PARTNERS AGads | $414,000 | +67.4% | 100,000 | +151.6% | 0.06% | +61.1% |
| EQ | EQUILLIUM INC | $296,000 | -1.3% | 400,000 | 0.0% | 0.04% | -4.5% | |
| New | XERIS BIOPHARMA HOLDINGS INC | $279,000 | – | 150,000 | +100.0% | 0.04% | – | |
| STIM | NEURONETICS INC | $270,000 | -37.2% | 200,000 | 0.0% | 0.04% | -39.7% | |
| PASG | Buy | PASSAGE BIO INC | $263,200 | -6.8% | 400,000 | +33.3% | 0.04% | -11.9% |
| GENEDX HOLDINGS CORP | $231,636 | -38.9% | 63,636 | 0.0% | 0.03% | -41.1% | ||
| ACELRX PHARMACEUTICALS INC | $113,100 | -47.7% | 195,000 | 0.0% | 0.02% | -50.0% | ||
| New | TRANSCODE THERAPEUTICS INC | $42,232 | – | 84,010 | +100.0% | 0.01% | – | |
| CREG | Exit | SMART POWERR CORP | $0 | – | -125,061 | -100.0% | -0.03% | – |
| Exit | FREELINE THERAPEUTICS HLDGSsponsored ads | $0 | – | -100,000 | -100.0% | -0.04% | – | |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -20,000 | -100.0% | -0.16% | – |
| BKU | Exit | BANKUNITED INC | $0 | – | -100,000 | -100.0% | -0.32% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.32% | – | |
| Exit | 2SEVENTY BIO INC | $0 | – | -250,000 | -100.0% | -0.37% | – | |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -1,945,206 | -100.0% | -0.52% | – | |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.53% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -1,787,775 | -100.0% | -0.67% | – | |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -6,060,000 | -100.0% | -0.68% | – |
| COF | Exit | CAPITAL ONE FINL CORP | $0 | – | -80,000 | -100.0% | -1.29% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.